Hudson Executive Capital’s AtriCure ATRC Stock Holding History

Hudson Executive Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-87,678	Closed	-$2.19M	–	9
2019 Q3	$2.19M	Sell	87,678 -100,000	-53%	-$2.86M	0.17%	12
2019 Q2	$5.6M	Sell	187,678 -260,300	-58%	-$7.6M	0.54%	11
2019 Q1	$12M	Sell	447,978 -881,511	-66%	-$26.8M	1.11%	9
2018 Q4	$40.7M	Sell	1,329,489 -1,044,630	-44%	-$32.5M	4.11%	4
2018 Q3	$83.2M	Hold	2,374,119	–	–	6.72%	4
2018 Q2	$64.2M	Hold	2,374,119	–	–	14.3%	3
2018 Q1	$48.7M	Buy	2,374,119 +368,509	+18%	+$6.65M	14.37%	3
2017 Q4	$36.6M	Buy	2,005,610 +150,610	+8%	+$2.98M	17.56%	3
2017 Q3	$41.5M	Hold	1,855,000	–	–	20.87%	3
2017 Q2	$45M	Hold	1,855,000	–	–	20.67%	3
2017 Q1	$35.5M	Buy	1,855,000 +769,400	+71%	+$13.5M	9.74%	6
2016 Q4	$21.2M	Buy	1,085,600 +567,420	+110%	+$10.3M	7.55%	5
2016 Q3	$8.2M	Buy	+518,180	New	+$7.97M	1.45%	11

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Hudson Executive Capital's ATRC Position: Q4 2019 in Review

Hudson Executive Capital sold out of AtriCure (ATRC) in Q4 2019, closing a stake of 87,678 shares — an estimated $2.19M sold.

Hudson Executive Capital first reported a position in ATRC in Q3 2016 and held it in 13 quarters. The position peaked at $83.2M in Q3 2018. 141 funds tracked by Wall St. Rank hold ATRC as of Q4 2019.

Hudson Executive Capital reported no remaining AtriCure position as of Q4 2019 after selling out during the quarter.
Hudson Executive Capital sold 87,678 AtriCure shares in Q4 2019, an estimated $2.19M.
Hudson Executive Capital first reported a position in AtriCure in Q3 2016 and held it in 13 quarters.
Hudson Executive Capital's AtriCure position peaked at $83.2M in Q3 2018.
141 funds tracked by Wall St. Rank held AtriCure as of Q4 2019.

Based on Hudson Executive Capital's 13F filing for Q4 2019, filed 14 Feb 2020.